Abstract
Introduction: Global developmental delay (DD), intellectual disability (ID), and autism spectrum disorder (ASD) are mainly evaluated under the neurodevelopmental disorder framework. In this study, we aimed to determine the genetic diagnosis yield using step-by-step genetic analysis in 38 patients with unexplained ID/DD and/or ASD. Methods: In 38 cases (27 male, 11 female) with unexplained ID/DD and/or ASD, chromosomal microarray (CMA) analysis, clinical exome sequencing (CES), and whole-exome sequencing (WES) analysis were applied, respectively. Results: We found a diagnostic rate of only CMA analysis as 21% (8/38) presenting 8 pathogenic and likely pathogenic CNVs. The rate of patients diagnosed with CES/WES methods was 32.2% (10/31). When all pathogenic and likely pathogenic variants were evaluated, the diagnosis rate was 44.7% (17/38). A dual diagnosis was obtained in a case with 16p11.2 microduplication and de novo SNV. We identified eight novel variants: TUBA1A (c.787C>G), TMEM63A (c.334-2A>G), YY1AP1 (c.2051_2052del), ABCA13 (c.12064C>T), ABCA13 (c.13187G>A), USP9X (c.1189T>C), ANKRD17 (c.328_330dup), and GRIA4 (c.17G>A). Conclusion: We present diagnostic rates of a complementary approach to genetic analysis (CMA, CES, and WES). The combined use of genetic analysis methods in unexplained ID/DD and/or ASD cases has contributed significantly to diagnosis rates. Also, we present detailed clinical characteristics to improve genotype-phenotype correlation in the literature for rare and novel variants.
References
1.
Blesson
A
, Cohen
JS
. Genetic counseling in neurodevelopmental disorders
. Cold Spring Harb Perspect Med
. 2020
;10
(4
):a036533
.2.
Bolger
AM
, Lohse
M
, Usadel
B
. Trimmomatic: a flexible trimmer for Illumina sequence data
. Bioinformatics
. 2014
;30
(15
):2114
–20
.3.
Chaves
TF
, Baretto
N
, Oliveira
LFd
, Ocampos
M
, Barbato
IT
, Anselmi
M
, . Copy number variations in a cohort of 420 individuals with neurodevelopmental disorders from the south of Brazil
. Sci Rep
. 2019
;9
(1
):17776
.4.
Chen
CH
, Huang
YS
, Fang
TH
. Involvement of rare mutations of SCN9A, DPP4, ABCA13, and SYT14 in schizophrenia and bipolar disorder
. Int J Mol Sci
. 2021
;22
(24
):13189
.5.
Elmas
M
, Yıldız
H
, Erdoğan
M
, Gogus
B
, Avcı
K
, Solak
M
. Comparison of clinical parameters with whole exome sequencing analysis results of autosomal recessive patients; a center experience
. Mol Biol Rep
. 2019
;46
(1
):287
–99
.6.
Fukumura
S
, Hiraide
T
, Yamamoto
A
, Tsuchida
K
, Aoto
K
, Nakashima
M
. A novel de novo TMEM63A variant in a patient with severe hypomyelination and global developmental delay
. Brain Dev
. 2022
;44
(2
):178
–83
.7.
Gürkan
H
, Atli
Eİ
, Atli
E
, Bozatli
L
, Altay
MA
, Yalcintepe
S
, . Chromosomal microarray analysis in Turkish patients with unexplained developmental delay and intellectual developmental disorders
. Noro Psikiyatr Ars
. 2020
;57
(3
):177
–91
.8.
Hiraide
T
, Yamoto
K
, Masunaga
Y
, Asahina
M
, Endoh
Y
, Ohkubo
Y
, . Genetic and phenotypic analysis of 101 patients with developmental delay or intellectual disability using whole-exome sequencing
. Clin Genet
. 2021
;100
(1
):40
–50
.9.
Huang
J
, Liu
J
, Tian
R
, Liu
K
, Zhuang
P
, Sherman
HT
, . A next generation sequencing-based protocol for screening of variants of concern in autism spectrum disorder
. Cells
. 2021
;11
(1
):10
.10.
Iritani
S
, Torii
Y
, Habuchi
C
, Sekiguchi
H
, Fujishiro
H
, Yoshida
M
, . The neuropathological investigation of the brain in a monkey model of autism spectrum disorder with ABCA13 deletion
. Int J Dev Neurosci
. 2018
;71
:130
–9
.11.
Kamath
V
, Yoganathan
S
, Thomas
MM
, Gowri
M
, Chacko
MP
. Utility of chromosomal microarray in children with unexplained developmental delay/intellectual disability
. Fetal Pediatr Pathol
. 2022
;41
(2
):208
–18
.12.
Li
H
, Durbin
R
. Fast and accurate short read alignment with Burrows-Wheeler transform
. Bioinformatics
. 2009
;25
(14
):1754
–60
.13.
Liu
Y
, Chang
X
, Qu
HQ
, Tian
L
, Glessner
J
, Qu
J
, . Rare recurrent variants in noncoding regions impact attention-deficit hyperactivity disorder (ADHD) gene networks in children of both African American and European American ancestry
. Genes
. 2021
;12
(2
):310
.14.
Liu
Y
, Lv
Y
, Zarrei
M
, Dong
R
, Yang
X
, Higginbotham
EJ
, . Chromosomal microarray analysis of 410 Han Chinese patients with autism spectrum disorder or unexplained intellectual disability and developmental delay
. NPJ Genom Med
. 2022
;7
:1
–10
.15.
Maia
N
, Nabais Sá
MJ
, Oliveira
C
, Santos
F
, Soares
CA
, Prior
C
, . Can the synergic contribution of multigenic variants explain the clinical and cellular phenotypes of a neurodevelopmental disorder
. Genes
. 2021
;13
(1
):78
.16.
Martin
J
, Cooper
M
, Hamshere
ML
, Pocklington
A
, Scherer
SW
, Kent
L
, . Biological overlap of attention-deficit/hyperactivity disorder and autism spectrum disorder: evidence from copy number variants
. J Am Acad Child Adolesc Psychiatry
. 2014
;53
(7
):761e26
–70e26
.17.
Miller
DT
, Adam
MP
, Aradhya
S
, Biesecker
LG
, Brothman
AR
, Carter
NP
, . Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies
. Am J Hum Genet
. 2010
;86
(5
):749
–64
.18.
Misra
S
, Peters
G
, Barnes
E
, Ardern-Holmes
S
, Webster
R
, Troedson
C
, . Yield of comparative genomic hybridization microarray in pediatric neurology practice
. Neurol Genet
. 2019
;5
(6
):e367
.19.
Mithyantha
R
, Kneen
R
, McCann
E
, Gladstone
M
. Current evidence-based recommendations on investigating children with global developmental delay
. Arch Dis Child
. 2017
;102
(11
):1071
–6
.20.
Nambot
S
, Thevenon
J
, Kuentz
P
, Duffourd
Y
, Tisserant
E
, Bruel
AL
, . Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis
. Genet Med
. 2018
;20
(6
):645
–54
.21.
Nava
C
, Keren
B
, Mignot
C
, Rastetter
A
, Chantot-Bastaraud
S
, Faudet
A
, . Prospective diagnostic analysis of copy number variants using SNP microarrays in individuals with autism spectrum disorders
. Eur J Hum Genet
. 2014
;22
(1
):71
–8
.22.
Pillai
NR
, Marafi
D
, Monteiro
SA
, Parnes
M
, Chandy
BM
, Patel
A
, . Novel deletion of 6p21. 31p21. 1 associated with laryngeal cleft, developmental delay, dysmorphic features and vascular anomaly
. Eur J Med Genet
. 2019
;62
(6
):103531
.23.
Posey
JE
, Harel
T
, Liu
P
, Rosenfeld
JA
, James
RA
, Coban Akdemir
ZH
, . Resolution of disease phenotypes resulting from multilocus genomic variation
. N Engl J Med
. 2017
;376
(1
):21
–31
.24.
Prasad
A
, Merico
D
, Thiruvahindrapuram
B
, Wei
J
, Lionel
AC
, Sato
D
, . A discovery resource of rare copy number variations in individuals with autism spectrum disorder
. G3
. 2012
;2
(12
):1665
–85
.25.
Richards
S
, Aziz
N
, Bale
S
, Bick
D
, Das
S
, Gastier-Foster
J
, . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
. Genet Med
. 2015
;17
(5
):405
–24
.26.
Schalock
RL
, Luckasson
RA
, Shogren
KA
, Borthwick-Duffy
S
, Bradley
V
, Buntinx
WHE
, . The renaming of mental retardation: understanding the change to the term intellectual disability
. Intellect Dev Disabil
. 2007
;45
(2
):116
–24
.27.
Shan
L
, Feng
JY
, Wang
TT
, Xu
ZD
, Jia
FY
. Prevalence and developmental profiles of autism spectrum disorders in children with global developmental delay
. Front Psychiatry
. 2021
;12
:794238
.28.
Srivastava
S
, Love-Nichols
JA
, Dies
KA
, Ledbetter
DH
, Martin
CL
, Chung
WK
, . Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders
. Genet Med
. 2019
;21
(11
):2413
–21
.29.
Tonduti
D
, Mura
E
, Masnada
S
, Bertini
E
, Aiello
C
, Zini
D
, . Spinal cord involvement and paroxysmal events in “Infantile Onset Transient Hypomyelination” due to TMEM63A mutation
. J Hum Genet
. 2021
;66
(10
):1035
–7
.30.
Türkyılmaz
A
, Geckinli
BB
, Tekin
E
, Ates
EA
, Yarali
O
, Cebi
AH
. Array-Based Comparative Genomic Hybridization Analysis in Children with Developmental Delay/Intellectual Disability
. Balkan J Med Genet
. 2022
;24
(2
):15
–24
.31.
Ueoka
I
, Kawashima
H
, Konishi
A
, Aoki
M
, Tanaka
R
, Yoshida
H
, . Novel Drosophila model for psychiatric disorders including autism spectrum disorder by targeting of ATP-binding cassette protein A
. Exp Neurol
. 2018
;300
:51
–9
.32.
Van Daalen
E
, Kemner
C
, Verbeek
NE
, van der Zwaag
B
, Dijkhuizen
T
, Rump
P
, . Social Responsiveness Scale-aided analysis of the clinical impact of copy number variations in autism
. Neurogenetics
. 2011
;12
(4
):315
–23
.33.
Yan
H
, Helman
G
, Murthy
SE
, Ji
H
, Crawford
J
, Kubisiak
T
, . Heterozygous variants in the mechanosensitive ion channel TMEM63A result in transient hypomyelination during infancy
. Am J Hum Genet
. 2019
;105
(5
):996
–1004
.34.
Yan
H
, Ji
H
, Kubisiak
T
, Wu
Y
, Xiao
J
, Gu
Q
, . Genetic analysis of 20 patients with hypomyelinating leukodystrophy by trio-based whole-exome sequencing
. J Hum Genet
. 2021
;66
(8
):761
–8
.35.
Yun
EH
, Kang
YH
, Lim
MK
, Oh
JK
, Son
JM
. The role of social support and social networks in smoking behavior among middle and older aged people in rural areas of South Korea: a cross-sectional study
. BMC Public Health
. 2010
;10
:78
–8
.© 2023 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2023
You do not currently have access to this content.
